BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33560682)

  • 41. Management of HCV-related end-stage liver disease in HIV-coinfected patients.
    Merchante N; Jiménez-Saenz M; Pineda JA
    AIDS Rev; 2007; 9(3):131-9. PubMed ID: 17982938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of hepatocellular carcinoma in people with HIV in the United States, 2001-2019.
    McGee-Avila JK; Argirion I; Engels EA; O'Brien TR; Horner MJ; Qiao B; Monterosso A; Luo Q; Shiels MS
    J Natl Cancer Inst; 2024 Jan; 116(1):61-68. PubMed ID: 37610358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and predictors of liver disease in HIV-infected children and adolescents.
    Pokorska-Śpiewak M; Stańska-Perka A; Popielska J; Ołdakowska A; Coupland U; Zawadka K; Szczepańska-Putz M; Marczyńska M
    Sci Rep; 2017 Sep; 7(1):12309. PubMed ID: 28951598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.
    Li Y; Xie J; Han Y; Wang H; Lv W; Guo F; Qiu Z; Li Y; Du S; Song X; Zhu T; Thio CL; Li T
    Medicine (Baltimore); 2016 Feb; 95(5):e2660. PubMed ID: 26844493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver-related Events in Human Immunodeficiency Virus-infected Persons With Occult Cirrhosis.
    Benmassaoud A; Nitulescu R; Pembroke T; Halme AS; Ghali P; Deschenes M; Wong P; Klein MB; Sebastiani G
    Clin Infect Dis; 2019 Sep; 69(8):1422-1430. PubMed ID: 30561558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of liver cirrhosis over ten consecutive years in Southern China.
    Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
    World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
    Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
    Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia.
    Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):541-546. PubMed ID: 32660841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
    Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
    J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.
    Zampino R; Pisaturo MA; Cirillo G; Marrone A; Macera M; Rinaldi L; Stanzione M; Durante-Mangoni E; Gentile I; Sagnelli E; Signoriello G; Miraglia Del Giudice E; Adinolfi LE; Coppola N
    Ann Hepatol; 2015; 14(1):75-82. PubMed ID: 25536644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
    Lui GC; Hui VW; Sze SF; Wong BC; Cheung C; Lee MP; Yip TC; Tse YK; Lai JC; Chan HL; Wong VW; Hui YT; Wong GL
    Aliment Pharmacol Ther; 2023 Oct; 58(8):814-823. PubMed ID: 37515399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network.
    Chang IC; Huang SF; Chen PJ; Chen CL; Chen CL; Wu CC; Tsai CC; Lee PH; Chen MF; Lee CM; Yu HC; Lo GH; Yeh CT; Hong CC; Eng HL; Wang J; Tseng HH; Hsiao CH; Wu HI; Yen TC; Liaw YF
    Medicine (Baltimore); 2016 Apr; 95(15):e3284. PubMed ID: 27082566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma.
    Hiotis SP; Rahbari NN; Villanueva GA; Klegar E; Luan W; Wang Q; Yee HT
    BMC Gastroenterol; 2012 Jun; 12():64. PubMed ID: 22681852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome.
    Puoti M; Bruno R; Soriano V; Donato F; Gaeta GB; Quinzan GP; Precone D; Gelatti U; Asensi V; Vaccher E;
    AIDS; 2004 Nov; 18(17):2285-93. PubMed ID: 15577541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
    Kee KM; Lu SN
    Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
    Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
    JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
    Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
    Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.